Hiddemann W - Search Results

1

Effect of very high-dose thymidine infusions on leukemia and lymphoma patients.

Blumenreich MS, Woodcock TM, Andreeff M, Hiddemann W, Chou TC, Vale K, O'Hehir M, Clarkson BD, Young CW. Blumenreich MS, et al. Among authors: hiddemann w. Cancer Res. 1984 May;44(5):2203-7. Cancer Res. 1984. PMID: 6713407

Cytoreduction was evaluated by the technique of W. Hiddemann, B. D. Clarkson, T. Buchener, M. R. Melamed, and M. Andreeff (Blood, 59: 216-225, 1982). ...

Cytoreduction was evaluated by the technique of W. Hiddemann, B. D. Clarkson, T. Buchener, M. R. Melamed, and M. Andreeff (Blo …

2

Cell kinetics in acute leukemia: a critical reevaluation based on new data.

Hiddemann W, Büchner T, Andreeff M, Wörmann B, Melamed MR, Clarkson BD. Hiddemann W, et al. Cancer. 1982 Jul 15;50(2):250-8. doi: 10.1002/1097-0142(19820715)50:2<250::aid-cncr2820500215>3.0.co;2-4. Cancer. 1982. PMID: 7083131

3

Bone marrow biopsy instead of 'marrow juice' for cell kinetic analysis. Comparison of bone marrow biopsy and aspiration material.

Hiddemann W, Büchner T, Andreeff M, Wörmann B, Melamed MR, Clarkson BD. Hiddemann W, et al. Leuk Res. 1982;6(4):601-12. doi: 10.1016/0145-2126(82)90016-9. Leuk Res. 1982. PMID: 6183535

4

Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute leukemia.

Hiddemann W, Clarkson BD, Büchner T, Melamed MR, Andreeff M. Hiddemann W, et al. Blood. 1982 Feb;59(2):216-25. Blood. 1982. PMID: 7055637 Free article.

5

[Comparison of the therapeutic efficacity of 2 induction protocols in acute myeloid leukemia using exact quantification of bone marrow cellularity].

Hiddemann W, Büchner T, Andreeff M, Arlin Z, Wörmann B, Clarkson BD. Hiddemann W, et al. Onkologie. 1983 Aug;6(4):179-83. doi: 10.1159/000215229. Onkologie. 1983. PMID: 6355946 German.

6

Quantitation of chemotherapy-induced cytoreduction in acute leukemia.

Hiddemann W, Andreeff M, Clarkson BD. Hiddemann W, et al. Haematol Blood Transfus. 1981;26:73-6. doi: 10.1007/978-3-642-67984-1_11. Haematol Blood Transfus. 1981. PMID: 7319296 No abstract available.

7

Treatment of relapsed or refractory adult acute lymphocytic leukemia.

Freund M, Diedrich H, Ganser A, Gramatzki M, Heil G, Heyll A, Henke M, Hiddemann W, Haas R, Kuse R, et al. Freund M, et al. Among authors: hiddemann w. Cancer. 1992 Feb 1;69(3):709-16. doi: 10.1002/1097-0142(19920201)69:3<709::aid-cncr2820690318>3.0.co;2-g. Cancer. 1992. PMID: 1730121

8

Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphoma.

Ho AD, del Valle F, Rückle H, Schwammborn J, Schlimok G, Hiddemann W, Meusers P, Thiel E, Dörken B, Hunstein W. Ho AD, et al. Among authors: hiddemann w. Cancer. 1989 Oct 1;64(7):1388-92. doi: 10.1002/1097-0142(19891001)64:7<1388::aid-cncr2820640703>3.0.co;2-0. Cancer. 1989. PMID: 2776103

9

DNA aneuploidies in adult patients with acute myeloid leukemia. Incidence and relation to patient characteristics and morphologic subtypes.

Hiddemann W, Wörmann B, Göhde W, Büchner T. Hiddemann W, et al. Cancer. 1986 Jun 1;57(11):2146-52. doi: 10.1002/1097-0142(19860601)57:11<2146::aid-cncr2820571111>3.0.co;2-5. Cancer. 1986. PMID: 3457625

10

High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias. Results of a clinical phase II study.

Kern W, Schleyer E, Unterhalt M, Wörmann B, Büchner T, Hiddemann W. Kern W, et al. Among authors: hiddemann w. Cancer. 1997 Jan 1;79(1):59-68. Cancer. 1997. PMID: 8988727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

915 results

Search Page

Filters